CERo Therapeutics Holdings - Warrants (13/02/2029) Accounts Payable

The latest accounts payable for CEROW is $7.7M as of March 2026. That compares with $6.4M in the prior-year period — up 20.5% year over year. Investors often review this figure alongside CERo Therapeutics Holdings - Warrants (13/02/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CEROW's accounts payable moved from $6.4M to $7.7M — a 20.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CERo Therapeutics Holdings - Warrants (13/02/2029)'s operating scale or balance-sheet position.

A accounts payable figure of $7.7M for CEROW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CEROW's accounts payable ($7.7M), review year-over-year change from $6.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.